Exparel - Non-Opioid Analgesic Pain Management for Single-Dose Infiltration
EXPAREL is indicated for single-dose infiltration in patients aged 6 years and older to produce postsurgical local analgesia and in adults as an interscalene brachial plexus nerve block to produce postsurgical regional analgesia. Safety and efficacy have not been established in other nerve blocks.
Single-dose, long-lasting EXPAREL® (bupivacaine liposome injectable suspension) as part of a multimodal approach, reduces postsurgical pain and can minimize the use of opioids
- EXPAREL eliminates the need for pumps and catheters that could hinder patient recovery1
EXPAREL is different than other local analgesics
EXPAREL uses proprietary multivesicular liposome (pMVL) technology to extend analgesia2
DESIGNED
to deliver controlled levels of bupivacaine2
COMPOSED
of naturally occurring, biocompatible lipids3-5
ENCAPSULATES
bupivacaine in a suspension of multivesicular liposomes
RELEASES
bupivacaine over time2
ACHIEVES
targeted local analgesia at the surgical site
PROVIDES
safe, consistent levels of bupivacaine2
ELIMINATES
the need for catheters and pumps that may hinder recovery1
EXTENDS
analgesic duration while reducing the need for opioids